Matthew D Tucker (Matthew Tucker)

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 4

Top Topics

Glycemic Control

Ejection Fraction

Metastatic Renal Cell Carcinoma

Prognostic Factors

Top Venues

Targeted oncology

Cancer medicine

Journal for immunotherapy of cancer

University of Alabama (BSC)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Alabama

United States

BSC :: Biology

Publications

Landon C Brown, Matthew D Tucker, Ramy Sedhom, Eric B Schwartz, Jason Zhu, Chester Kao, Matthew Kyle Labriola, Rajan T Gupta, Daniele Marin, Yuan Wu, Santosh Gupta, Tian Zhang, Michael R Harrison, Daniel J George, Ajjai Alva, Emmanuel S Antonarakis, Andrew J Armstrong
LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types. Journal for immunotherapy of cancer 9 (3) (2021)
Kunal B Desai, Landon C Brown, Wei Wei, Matthew D Tucker, Chester Kao, Emily Kinsey, Brian Rini, Kathryn E Beckermann, Tian Zhang, Moshe C Ornstein
A Multi-institutional, Retrospective Analysis of Patients with Metastatic Renal Cell Carcinoma to Bone Treated with Combination Ipilimumab and Nivolumab. Targeted oncology 16 (5) (2021)
Matthew D Tucker, Brian I Rini
Predicting Response to Immunotherapy in Metastatic Renal Cell Carcinoma. Cancers 12 (9) (2020)
Matthew D Tucker, Jason Zhu, Daniele Marin, Rajan T Gupta, Santosh Gupta, William R Berry, Sundhar Ramalingam, Tian Zhang, Michael Harrison, Yuan Wu, Patrick Healy, Stacey Lisi, Daniel J George, Andrew J Armstrong
Pembrolizumab in men with heavily treated metastatic castrate-resistant prostate cancer. Cancer medicine 8 (10) (2019)